KMT2C and neoplasm: We found that knockdown of KMT2C, a key molecule in the COMPASS complex, in human cuSCC cell lines accelerated in vitro proliferation and in vivo xenograft growth, supporting a role for this gene as a tumor suppressor in advanced disease.